Objective: We review the published data relating to intake of coffee and caffeine on blood pressure in man. We also refer to studies on the possible mechanisms of actions of these effects of caffeine. Design: The MEDLINE and Current Contents databases were searched from 1966 to April 1999 using the text words`coffee or caffeine' and`blood pressure or hypertension'. Controlled clinical and epidemiologic studies on the blood pressure effects of coffee or caffeine are reviewed. We also refer to studies on the possible mechanisms of action of these effects of caffeine. Results: Acute intake of coffee and caffeine increases blood pressure. Caffeine is probably the main active component in coffee. The pressor response is strongest in hypertensive subjects. Some studies with repeated administration of caffeine showed a persistent pressor effect, whereas in others chronic caffeine ingestion did not increase blood pressure. Epidemiologic studies have produced contradictory ®ndings regarding the association between blood pressure and coffee consumption. During regular use tolerance to the cardiovascular responses develops in some people, and therefore no systematic elevation of blood pressure in long-term and in population studies can be shown.
Introduction
Coffee is one of the most widely used non-alcoholic beverages in industrialized countries. Caffeine is an important component of this drink: a 150 ml cup of coffee contains about 60 ± 120 mg of caffeine (Barone & Roberts, 1996) . Other common dietary sources of caffeine are tea and cola soft drinks. The caffeine content in tea is aproximately 20 ± 40 mg per 150 ml cup, and that of cola soft drinks ranges from 15 to 24 mg per 180 ml serving. The consumption of coffee in Nordic countries is among the highest in the world; for instance, in Denmark the mean daily caffeine intake is approximately 7 mgakg (Barone & Roberts, 1996) . In addition, caffeine is used as an adjuvant in many prescription and over-the-counter drugs, e.g. in combination with nonsteroidal anti-in¯ammatory drugs in analgesic formulations and with ergotamine in drugs for treating migraine (Chou & Benowitz, 1994) . Combination of caffeine and ephedrine has also been reported to reduce weight in obese subjects, whereas both substances given alone had no effect (Astrup et al, 1992) .
Caffeine exerts a variety of stimulatory effects upon the central nervous system, and it is probably the most widely used psychoactive substance. It also increases the respiratory rate and causes bronchodilatation, stimulates lipolysis, and increases diuresis (Robertson et al, 1978; Chou & Benowitz, 1994) . Caffeine produces a variety of adverse effects, including gastrointestinal disturbances, tremor, headache and insomnia (Chou & Benowitz, 1994) . It can also induce palpitations and sometimes even cardiac arrhythmias (Mehta et al, 1997) , and it has been suggested that caffeine may be potentially hypertensive (James 1997; Jee et al, 1999) .
Caffeine is readily absorbed from the gastrointestinal tract and rapidly distributed in all the body¯uids (Chou & Benowitz, 1994) . There is, however, considerable interindividual variability in the rate of absorption. The peak plasma concentrations of caffeine are usually obtained within 30 ± 120 min of oral intake (Robertson et al, 1978; Smits et al, 1985 Smits et al, , 1986a . Caffeine is extensively metabolized in the liver via a complex set of reactions. The primary pathway is oxidative N-demethylation to paraxanthine, theobromine, theophylline and direct ring oxidation to 1,3,7-trimethyluric acid (Tang-Liu et al, 1983) . The elimination half-life of caffeine in man ranges from 2 ± 10 h, with a mean of about 4 ± 5 h (Robertson et al, 1981; Tang-Liu et al, 1983; Smits et al, 1985) . A dose-dependent pharmacokinetics may occur, which means that enzymes involved in metabolism become saturated (Tang-Liu et al, 1983) . The metabolism is slowed during pregnancy (Knutti et al, 1981) and in women taking oral contraceptives (Callahan et al, 1983) . On the other hand, the clearance rate of caffeine is greater in smokers than in non-smokers (Parsons & Neims, 1978) .
Coffee and other caffeine-containing beverages are widely consumed on a daily basis. It is therefore important to de®ne the possible risks and bene®ts associated with caffeine intake, in order to be able to better inform both health professionals and the public. The possible association between coffee consumption and increased risk of coronary heart disease has been debated for decades without any clear agreement of causal relation Greenland, 1993; Chou & Benowitz, 1994; Kawachi et al, 1994; Thompson, 1994) . Possible risk factors predisposing consumers to caffeine-induced coronary heart disease may include blood pressure and plasma cholesterol levels elevated by coffee.
The objective of this overview is to summarize current knowledge of the effects of coffee and caffeine intake on blood pressure. The possible mechanisms of these responses will also be discussed. The relation between coffee consumption and plasma lipids has been reviewed elsewhere (Thelle et al, 1987; Pirich et al, 1993 , Thompson, 1994 ) and is therefore not included in this article.SBP, systolic blood pressure; DBP, diastolic blood pressure.
Methods
The MEDLINE and the Current Contents literature searches for published articles in English from January 1966 to April 1999 were carried out using the keywords coffee or caffeine' and`blood pressure or hypertension'. Articles concerning human epidemiological and controlled clinical studies that have relevant data on the effects of coffee or caffeine on blood pressure were included in the present review. In addition, reference lists were reviewed to obtain applicable articles. We also referred to animal and in vitro studies that dealt with the possible mechanisms of actions of the cardiovascular effects of coffee or caffeine. The inclusion criteria for clinical trials were a controlled study design and random assignment. Exclusion criteria were an open study design, the numerical values of the blood pressure not given or statistical analysis not performed.
Epidemiologic studies on coffee and blood pressure
Several cross-sectional and longitudinal epidemiologic studies have evaluated the effects of coffee and caffeine intake on blood pressure (Table 1) . However, the results have remained inconsistent. Some of these studies found that habitual consumption of coffee or caffeine was associated with slightly elevated blood pressure (Lang et al, 1983a, b; Birkett & Logan, 1988; Lo Èwik et al, 1991; Burke et al, 1992; Narkiewicz et al, 1995) . However, many of the epidemiologic studies showed no relation (Shirlow et al, 1988; Wilson et al, 1989; Ho Èfer & Ba Èttig, 1993; Lewis et al, 1993) , and some even showed a small inverse association between self-reported coffee consumption and blood pressure (Periti et al, 1987; Stensvold et al, 1989; Salvaggio et al, 1990; Gyntelberg et al, 1995; Wakabayashi et al, 1998) . Consumption of coffee appears to be positively associated with an increased risk of thromboembolic stroke in middle-aged hypertensive men (Hakim et al, 1998) .
Development of tolerance during habitual use may explain why coffee consumption in some epidemiologic studies did not appear to have a clear effect on blood pressure. However, a large cross-sectional study with over 5000 participants found that caffeine consumption within the last 3 h was associated with signi®cantly higher blood pressure than when caffeine was not consumed in the last 9 h (Shirlow et al, 1988) . A smaller study with 338 female subjects also con®rmed that recent coffee consumption was related to increased blood pressure (Ho Èfer & Ba Èttig, 1993) . In some of the epidemiologic studies blood pressure measurements were taken under conditions when fasting was required from the participants (Salvaggio et al, 1990; Lewis et al, 1993; Gyntelberg et al, 1995) . This may have led to an underestimation of the blood pressure levels in the studies with negative results, because caffeine deprivation has been associated with lower blood pressure in habitual consumers (James, 1994; Phillips-Bute & Lane, 1998) . Thus, the inverse association between coffee intake and blood pressure observed in some epidemiologic studies (Salvaggio et al, 1990; Gyntelberg et al, 1995 ) is consistent Burke et al (1992) Australia 843 M F 60 ± 87 BP was positively related to coffee drinking in subjects treated with antihypertensive drugs. No signi®cant association between coffee drinking and BP in untreated subjects was found Ho Èfer & Ba Èttig (1993) Switzerland 338 F 20 ± 40 Actual coffee consumption on the testing day was associated with elevated BP (0.7 ± 2 mmHg per cup of coffee). Habitual coffee consumption was unrelated to BP Lang et al (1983a) Algeria 1 491 M F 15 ± 70 DBP was 2 mmHg higher among coffee drinkers than among nondrinkers Lang et al (1983b) France 6 321 M F 18 ± 60 SBP was 2 ± 4 mmHg higher among coffee drinkers than among nondrinkers Lewis et al (1993) USA 5 115 M F 18 ± 30 Caffeine intake (up to 800 mgaday) was unrelated to BP Lo Èwik et al (1991) Netherlands 255 M F 65 ± 79 Coffee consumption was positively correlated with BP among women Narkiewicz et al (1995) Italy 887 M F 18 ± 45 Daytime SBP was 2.5 mmHg higher in men who consumed coffee ! 4 cupsaday than in men who did not drink coffee Periti et al (1987) Italy 500 M F 18 ± 62 SBP and DBP were 0.8 and 0.5 mmHg lower per daily consumed cup of coffee Salvaggio et al (1990) Italy 9 601 M F 18 ± 65 Increasingly lower BP with increases in coffee consumption; those who drank 4 ± 5 cupsaday had SBP and DBP 2 ± 3 and 1 mmHg lower than nondrinkers Sharp & Benowitz (1990) USA 247 A positive correlation between plasma levels of caffeine and BP in infrequent caffeine users but not in habitual users Shirlow et al (1988) Australia 5 147 M F 20 ± 70 Caffeine intake within the last 3 h was associated with 2 ± 4 mmHg higher BP. Average daily caffeine consumption was not associated with BP Stensvold et al (1989) Norway 29 027 M F 40 ± 42 An inverse U-shaped relation between coffee consumption and BP, the mean values being lowest for 0 and ! 9 cupsaday Wakabayashi et al (1998) Japan 3 336 M 48 ± 56 SBP and DBP were 0.6 and 0.4 mmHg lower per daily consumed cup of coffee
Longitudinal studies Gyntelberg et al (1988) Denmark 2 975 M 53 ± 74 DBP was negatively associated with coffee consumption in coffee drinkers Wilson et al (1989) USA 5 209 M F Middle-aged Coffee consumption was unrelated to SBP SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure.
Coffee, caffeine and blood pressure M-L Nurminen et al with the lower blood pressure in regular users of coffee during caffeine withdrawal.
Acute intake of coffee or caffeine and blood pressure
A rise in blood pressure after acute intake of coffee has been shown in many studies (Table 2) . It seems that caffeine is the active component responsible for this effect, because in several studies regular coffee intake increased blood pressure, whereas decaffeinated coffee had no effect (Smits et al, 1985; Ray et al, 1986; Myers et al, 1989; Nussberger et al, 1990) . In addition, no differences between the pressor effects of regular coffee and caffeine have been found (Casiglia et al, 1992) . A single dose of caffeine (200 ± 250 mg, equivalent to two to three cups of coffee) increases systolic blood pressure by 3 ± 14 mmHg and diastolic blood pressure by 4 ± 13 mmHg in normotensive subjects ( Table 2 ). The pressor effect coincides with the increase in plasma caffeine concentrations (Robertson et al, 1978; Haigh et al, 1993; Sung et al, 1994) . Blood pressure usually elevates within 30 min, and the maximal increase occurs 60 ± 120 min after caffeine intake (Robertson et al, 1978; Freestone & Ramsay 1982; Izzo et al, 1983; Nussberger et al, 1990; Sung et al, 1994) . The increase in blood pressure may last over 2 ± 4 h (Freestone & Ramsay 1982; Casiglia et al, 1992; Sung et al, 1994; Bender et al, 1997) . The pressor response to caffeine seems to be more pronounced in hypertensive or hypertension-prone subjects than in normotensive subjects (Smits et al, 1986a; Greenstadt et al, 1988; Sung et al, 1994; Lovallo et al, 1996b) . The effect has been shown to be additive or enhanced during mental and physical stress (Greenstadt et al, 1988; Pincomb et al, 1988 Pincomb et al, , 1991 Lovallo et al, 1989 Lovallo et al, , 1991 Lovallo et al, , 1996b Myers et al, 1989; Lane et al, 1990; France & Ditto, 1992) .
It has been suggested that the pressor effect of caffeine is stronger in older subjects than that seen in the young ones (Izzo et al, 1983; Massey, 1998) . No racial or sex differences have been found in blood pressure responses to caffeine Strickland et al, 1989; Bak & Grobbee, 1990; James, 1994) .
The pressor effect of acute caffeine intake is stronger in persons who do not normally consume caffeine than in habitual users of caffeine (Izzo et al, 1983; Casiglia et al, 1992) . The degree of blood pressure response associated with a single dose of caffeine seems to be inversely related to the plasma caffeine concentration at the time of administration, i.e. the greatest blood pressure response occurs in those subjects with the lowest caffeine concentration (Robertson et al, 1981) .
Repeated coffee or caffeine intake and blood pressure Despite the well-described pressor response to acute intake of coffee or caffeine, the evidence for long-term effects on blood pressure is inconclusive. The results of the studies Ray et al (1986) 9 4 mgakg caffeine 8 11 Robertson et al (1978) 9 21 ± 30 250 mg caffeine 14 10 Smits et al (1983) 12 17 ± 38 2 cups of coffee 5 11 Smits et al (1985) 8 21 ± 25 300 ml coffee 4 ± 5 8 ± 9 Smits et al (1986a) 10 19 ± 37 2 cups of coffee 5 11 Sung et al (1994) 12 30 ± 45 3.3 mgakg caffeine 9 8
Hypertensive or borderline hypertensive subjects Freestone & Ramsay (1982) 16 500 ml coffee 10 7 ( % 200 mg caffeine) Goldstein & Shapiro (1987) 18 37 ± 60 200 mg caffeine 8 6 Lovallo et al (1996b) 24 20 ± 39 3.3 mgakg caffeine 11 8 Smits et al (1986a) 10 18 ± 56 2 cups of coffee 13 11 Sung et al (1994) 18 30 ± 45 3.3 mgakg caffeine 12 11 SBP, systolic blood pressure; DBP, diastolic blood pressure.
Coffee, caffeine and blood pressure M-L Nurminen et al Rakic et al (1999) 26 54 ± 89 Instant coffee 5 cups 2 weeks Mean 24 h SBP and DBP was 4.8 and 3.0 Caffeine-free diet 2 weeks mmHg higher in coffee drinkers than in abstainers SBP, systolic blood pressure; DBP, diastolic blood pressure.
Coffee, caffeine and blood pressure M-L Nurminen et al with repeated administration of coffee or caffeine are summarized in Table 3 . The effects of repeated caffeine intake have also been studied in controlled studies using continuous ambulatory monitoring to measure blood pressure (Table 4) . Some of the long-term studies have shown that caffeine induced persistent pressor effects (by 3 ± 6 mmHg) in habitual consumers (Ammon et al, 1983; Burr et al, 1989; James, 1994; Rakic et al, 1999) . Changing from caffeinated to decaffeinated coffee (van Dusseldorp et al, 1989; Superko et al, 1994) or abstinence from coffee (Bak & Grobbee, 1990; Superko et al, 1994) resulted in a slight fall (by 2 ± 5 mmHg) in blood pressure. However, other studies reported that chronic caffeine consumption or abstinence from caffeine were not accompanied by signi®cant changes in blood pressure (Rosmarin et al, 1990; Bak & Grobbee, 1991; van Dusseldorp et al, 1991; Superko et al, 1991; Ho Èfer & Ba Èttig, 1994) . In one double blind trial in obese subjects, reduction in blood pressure was observed during an energy-restricted diet combined with caffeine (200 mg63) for 6 months (Astrup et al, 1992) . However, blood pressure also reduced in the placebo group, and there was a pronounced weight loss by more than 10 kg in both groups. Because reduction in body weight lowers blood pressure in overweight subjects (Stevens et al, 1993) , it is very dif®cult to differentiate the in¯uence of caffeine alone in this study.
Daytime ambulatory blood pressure has generally been higher on caffeine days than on caffeine-free days (Jeong & Dimsdale 1990; James 1994; Superko et al, 1994; Green & Suls, 1996; Lane et al, 1998; Rakic et al, 1999) , whereas some studies which reported ambulatory blood pressure recordings as 24 h means have failed to detect this pressor effect (MacDonald et al, 1991; Eggertsen et al, 1993) (Table 4) .
Most of the long-term studies were of normotensive subjects, and there is relatively little information on the long-term effects of caffeine in hypertensive patients (Robertson et al, 1984; MacDonald et al, 1991; Eggertsen et al, 1993; Rakic et al, 1999) .
The failure to detect an increase in blood pressure caused by repeated adminstration of caffeine may be due to the development of tolerance. The pressor response has been reported as diminishing within a few days of the start of regular intake of caffeine (Robertson et al, 1981 (Robertson et al, , 1984 Ammon et al, 1983; Myers & Reeves, 1991) . However, the tolerance may be partial, because in some studies caffeine was still able to elevate blood pressure during habitual consumption (Burr et al, 1989; Jeong & Dimsdale 1990; James 1994; Green & Suls, 1996) . The pressor response to caffeine may be regained after a relatively short period of abstinence. Caffeine taken after only an overnight abstinence of 10 ± 12 h increased blood pressure in regular coffee drinkers (Freestone & Ramsay, 1982; Isso et al, 1983; Ray et al, 1986; Goldstein & Shapiro, 1987; Pincomb et al, 1988 Pincomb et al, , 1991 Myers et al, 1989; Lane et al, 1990; Lovallo et al, 1991 Lovallo et al, , 1996b Sung et al, 1994) . A pressor response to the second cup of coffee of the day within 1 ± 2 h of the ®rst morning cup has also been observed (Lane & Manus, 1989; Goldstein et al, 1990) . Thus, the cardiovascular effects of caffeine may persist, at least in part, during chronic consumption of caffeine. It is possible that some people have a higher sensitivity to caffeine or a lesser susceptibility to the development of tolerance to the pressor effect of caffeine.
A recent meta-analysis of 11 controlled clinical trial with 522 participants assessed the effect of coffee intake on blood pressure by comparing the coffee group with the nocoffee control group (Jee et al, 1999) . Studies which compared caffeine tablets with decaffeinated coffee were excluded. According to the meta-analysis, systolic and diastolic blood pressure increased by 0.8 mmHg (P`0.001) and 0.5 mmHg (P`0.01), respectively, for every cup of coffee during long-term coffee consumption (Jee et al, 1999) .
In hypertensive subjects the combination of coffee and smoking produced a stronger and more sustained pressor response than each stimulus alone (Freestone & Ramsay, 1982) . Moreover, in a cross-sectional observational study using 24 h ambulatory blood pressure monitoring, moderate smokers and coffee drinkers with mild hypertension had signi®cantly higher daytime blood pressure than nonsmokers and those who did not drink coffee (Narkiewicz et al, 1995) , which suggests that the effect might recur throughout the day, despite the increased caffeine catabolism in smokers (Parsons & Neims, 1978) .
Hemodynamic effects of caffeine
Acute intake of coffee or caffeine increased vascular resistance, indicating a vasoconstrictor effect (Pincomb et al, 1985 (Pincomb et al, , 1988 Smits et al, 1986a; Lovallo et al, 1991; Casiglia et al, 1992; Sung et al, 1994) . The pressor effect has often been accompanied by a small decrease in the heart rate (Izzo et al, 1983; Smits et al, 1983 Smits et al, , 1985 Smits et al, , 1986a Robertson et al, 1984; Sung et al, 1994) , or heart rate was not sign®cantly affected even after high doses of caffeine (Robertson et al, 1981; Ammon et al, 1983; Casiglia et al, 1992; Bender et al, 1997) . The caffeineinduced lowering of the heart rate may be a re¯ectory bradycardic response to pressor action or a direct effect on the cardiac or sino-atrial node. The re¯ex activation of baroreceptors is supported by a recent study using power spectral analysis, in which an increase in parasympathetic nerve activity was observed in normotensive subjects (Hibino et al, 1997) . On the other hand, a single dose of caffeine reduced baroreceptor sensitivity simultaneously with an increase in blood pressure in normotensive subjects (Mosqueda-Garcia et al, 1990) . The effects were not seen after multiple doses of caffeine over one week, possibly due to the development of tolerance to the hemodynamic effects of caffeine.
Palpitations sometimes associated with caffeine intake may be explained by an increased level of altertness or by an increased force of myocardial contraction (Myers & Reeves, 1991) . A positive inotropic effect of caffeine has been reported (Bender et al, 1997) , although in general, little or no effect on cardiac output at rest has been noted (Pincomb et al, 1985 Casiglia et al, 1992; Bender et al, 1997) . However, during stress an enhancement of myocardial contractility has been found to be accompanied by an increase in cardiac output (Pincomb et al, 1988; Lovallo et al, 1991) . The chronic effects of caffeine on cardiac output have not been studied.
Mechanisms of the cardiovascular effects of coffee and caffeine
The summary of the possible mechanisms of the cardiovascular effects of coffee and caffeine has been presented in Table 5 . The best known pharmacologically active substance in coffee is trimethylxanthine caffeine. The Coffee, caffeine and blood pressure M-L Nurminen et al main metabolite of caffeine, paraxanthine, also increased blood pressure in man (Benowitz et al, 1995) . Some of the cardiovascular effects of coffee may be mediated by a variety of substances other than caffeine, such as the lipid compounds cafestol and kahweol, which have been implicated as the components responsible for the hyperlipidemic effect of un®ltered coffee (Urgert & Katan, 1997) . Other chemicals identi®ed in coffee include chlorogenic acid, carbohydrates and peptides (Chou & Benowitz, 1994) . Both normal and decaffeinated coffee have been shown to contain muscarinic compound(s) that constricted coronary arteries in vivo (Kalsner, 1977 ). An extract which produced an abrupt depression of blood pressure and heart rate in rats and relaxed aortic rings in vitro has also been isolated from regular and decaffeinated instant coffee (Tse, 1992) .
Inhibition of phosphodiesterases
Caffeine could in¯uence vascular tone by inhibiting phosphodiesterases, with consequent increases in cyclic AMP and cyclic GMP levels (Kramer & Wells, 1979) . However, caffeine is a non-speci®c inhibitor of phosphodiesterases and is only effective in vitro at much higher concentrations (50% inhibitory concentration of 390 ± 500 mmolal; Kramer & Wells, 1979) than are achieved in vivo in plasma after two to three cups of coffee (20 ± 40 mmolal; Izzo et al, 1983; Smits et al, 1983; Cassiglia et al, 1992) . Caffeine induced vasoconstriction in humans, whereas enprofylline, a xanthine derivative which has prominent phosphodiesterase inhibiting effects, caused vasodilatation . Thus, inhibition of phosphodiesterases appears not to be the major mechanism mediating the cardiovascular effects of caffeine.
Antagonism of adenosine receptors
Caffeine exerts many of its actions by antagonizing adenosine receptors, of which four subtypes have been cloned and characterized (Fredholm, 1995; Olah & Stiles, 1995) . Adenosine dilates several vascular beds (Ohah & Stiles, 1995) . Based on studies with knockout mice lacking A 2a -receptors and having elevated blood pressure (Ledent et al, 1997) , adenosine seems to act as a physiological vasodilator. Thus, caffeine may cause an increase in blood pressure by antagonizing this effect of adenosine. The major targets of caffeine are A 1 and A 2a receptors, which can be blocked by caffeine at low micromolar concentrations similar to those that occur in plasma after consumption of a few cups of coffee (Fredholm, 1995) . In normotensive men, intravenous caffeine has been shown to reduce the hemodynamic effects of adenosine infusion .
Adenosine A 1 and A 2a receptors have partially opposite cellular effects. Stimulation of A 1 receptors causes the inhibition of adenylate cyclase and some types of calcium channels, and the activation of several types of potassium channels, as well as phospholipases C and D (Fredholm, 1995; Olah & Stiles, 1995) . Stimulation of A 2a receptors activates adenylate cyclase and probably voltage-sensitive calcium channels. The two subtypes of receptors may be co-expressed and activated simultaneously in the same cells (Fredholm, 1995) . The actions of caffeine are therefore complicated.
Adenosine also inhibits the release of many neural transmitters, e.g. noradrenaline, dopamine, acetylcholine, glutamate and GABA (Fredholm & Dunwiddie, 1988) . The excitatory transmitter release seems to be more inhibited than that of the inhibitory ones (Fredholm, 1995) . This may be related to activation of potassium channels via the A 1 receptors. By blocking these receptors, caffeine may facilitate the release of neurotransmitters.
Caffeine not only acts at the receptor level on the adenosine system, but in rats it can increase plasma concentration of adenosine, probably via a receptor-mediated mechanism at concentrations achieved by the daily human use of coffee (Conlay et al, 1997) .
Vascular effects and calcium
Caffeine produced transient contractions of arterial smooth muscle at millimolar concentrations in vitro (Kalsner, 1971; Karaki et al, 1987; Sato et al, 1988; Moriyama et al, 1989) , which were more marked in preparations from spontaneously hypertensive rats than from normotensive rats (Moriyama et al, 1989) . Caffeine-induced vascular contractions were reduced or blocked by removal of extracellular calcium or by the inhibition of calcium release from the sarcoplasmic reticulum (Sato et al, 1988; Moriyama et al, 1989) . It has been suggested that the mobilization of intracellular calcium by the so-called calciuminduced calcium release mechanism is crucial in caffeineinduced vasoconstriction (Karaki et al, 1987) . On the venous side in vitro, caffeine induced phasic contractions, which were dependent on both the in¯ux of extracellular calcium and the release of intracellular calcium (Shimamura et al, 1991) .
Studies on the role of calcium in¯ux through calcium channels in the pressor response to caffeine in man have been contradictory, because pretreatment with the slow Ltype calcium channel antagonist verapamil had no effect (Smits et al, 1986b) , whereas nifedipine reversed the increase in blood pressure caused by caffeine in normotensive subjects (van Nguyen & Myers, 1988) .
In addition to vasoconstriction, caffeine has also been shown to inhibit contractions in vascular smooth muscle (Ahn et al, 1988; Sato et al, 1988) , partly due to reduced cytoplasmic calcium and partly due to reduced sensitivity of the contractile elements to calcium (Sato et al, 1988) . Caffeine-induced relaxations in rat aortic rings consist partly of a nitric-oxide-dependent component and also of a component involving the inhibition of phosphodiesterases (Hatano et al, 1995) .
Sympathetic nervous system
Acute administration of coffee or caffeine increases the plasma concentrations of catecholamines, particularly adrenaline, and the urinary excretion of catecholamines (Robertson et al, 1978; Izzo et al, 1983; Smits et al, 1985; Pincomb et al, 1988; Lane et al, 1990; Nussberger et al, 1990; Narkiewicz et al, 1995) . The increase in plasma adrenaline is similar in normotensive and hypertensive subjects (Smits et al, 1986a) . In animal experiments caffeine activates tyrosine hydroxylase (Snider & Waldeck, 1974; Datta et al, 1996) , the ratelimiting enzyme in catecholamine biosynthesis. In addition, caffeine releases adrenal catecholamines, both directly and through neurogenic stimulation (Berkowitz & Spector, 1971; Snider & Waldeck, 1974) . It has also been speculated that the caffeine-induced increase in plasma catecholamines is due to inhibition of the extraneuronal metabolism of catecholamines (Kalsner, 1971 ).
An increase in blood pressure by caffeine was seen in some normotensive (Izzo et al, 1983) and hypertensive subjects as well as in adrenalectomized patients (Smits et al, 1986a) without an increase in plasma catecholamines. Caffeine also elevates blood pressure in subjects with autonomic dysfunction, in whom sympathetic responsiveness is lacking (Onrot et al, 1985; van Soeren et al, 1996) . Therefore, the pressor response to coffee is not purely the result of an increase in circulating catecholamines or the activation of the sympathetic nervous system.
Effects on adrenal cortex
In normotensive and hypertensive subjects, caffeine caused stress-like increases in plasma adrenocorticotropin (ACTH) and cortisol concentrations (Lovallo et al, 1996a) and potentiated stress-related increases in plasma cortisol (Pincomb et al, 1988; Lovallo et al, 1989; Lane et al, 1990) . Corticosteroids can in¯uence vascular tone, e.g. by enhancing reactivity to other vasoactive substances, such as catecholamines (Walker & Williams, 1992) .
Renal effects
Acute ingestion of caffeine slightly increased urinary volume and sodium excretion in humans (Robertson et al, 1978; Passmore et al, 1987; Nussberger et al, 1990) . The role of atrial natriuretic peptide (ANP) in the diuretic and natriuretic effects of caffeine is unclear, because the plasma concentrations of ANP were not affected by acute intake of caffeine (Nussberger et al, 1990) , whereas a signi®cant increase in circulating ANP was observed during 2 weeks of regular caffeine consumption (Eggertsen et al, 1993) . The plasma concentrations of antidiuretic hormone (vasopressin) remained unchanged after an acute intake of caffeine (Izzo et al, 1983; Nussberger et al, 1990) . On the other hand, in rats caffeine caused a marked dosedependent increase in renal prostaglandin excretion (Engelhardt, 1996) , which could, at least partly, explain the caffeine-induced diuresis.
Repeated administration of caffeine for one week caused renal vasoconstriction and lowered renal plasma¯ow in normotensive volunteers ingesting a high-salt diet (Brown et al, 1993) . Plasma renin activity was increased, which could have caused the renal vasoconstriction via increased angiotensin II concentrations. Acutely administered caffeine increased plasma renin activity in experimental animals (Ohnishi et al, 1987) and in man (Robertson et al, 1978 (Robertson et al, , 1981 , probably through the antagonism of adenosine receptors on juxtaglomerular cells (Kuan et al, 1990) . In some studies, however, no signi®cant effect of acute caffeine intake on plasma renin activity was observed (Passmore et al, 1987; Nussberger et al, 1990) , or else the increase was attenuated after chronic administration of caffeine (Robertson et al, 1981 (Robertson et al, , 1984 Eggertsen et al, 1993) . A decrease in plasma renin activity after an acute intake of coffee has also been reported (Smits et al, 1983 (Smits et al, , 1986a . Moreover, an inverse association between chronic coffee consumption and plasma renin activity has been observed in mildly hypertensive men (Palatini et al, 1996) . Thus, the importance of the renin ± angiotensin ± aldosterone system in the cardiovascular effects of caffeine remains unclear.
Conclusion
The acute pressor effect of coffee and caffeine is well documented, but the reports on the chronic effects on blood pressure are inconsistent. Large inter-individual variations in caffeine metabolism may contribute to the variability in the hemodynamic responses to chronic caffeine consumption. Differences in the extent of tolerance may also underlie the variations in sensitivity to blood pressure elevation caused by caffeine. Although there is at present no clear epidemiologic evidence that coffee consumption is causally related to hypertension, high intake of coffee may be an additional risk factor in the development of hypertension at the individual level, because some people seem to have a higher sensitivity to the cardiovascular effects of caffeine, e.g. due to long-lasting stress or to a generic susceptibility to hypertension. We conclude that coffee and caffeine in large doses may be harmful to some hypertensive or hypertension-prone subjects. Before more de®nite conclusions can be drawn, long-term clinical trials, as well as prospective epidemiologic studies with large numbers of participants, are needed.
